Viewing Study NCT02229227


Ignite Creation Date: 2025-12-25 @ 5:08 AM
Ignite Modification Date: 2026-02-26 @ 6:53 AM
Study NCT ID: NCT02229227
Status: COMPLETED
Last Update Posted: 2020-11-27
First Post: 2014-08-28
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus, Type 2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None switch study View
None albiglutide View
None glucagon-like peptide-1 receptor agonist View
None Type 2 diabetes mellitus View
None basal-bolus insulin therapy View